Total Funding
14
Total FundingPre-Seed raised
Growth Score
pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
314389
MYi wants to revolutionize preventative and personalized medicine.
- Maria Forero: Chief Business Officer
Nicholas Schork: Chief Executive Officer, Co-FounderPast Role: Genset, VP of Statistical Genomics
About the Company
MYI Diagnostics is a biomedical research company that specializes in multiplexed proteomic profiling for precision medicine. MYI Diagnostics conducts confidential research in order to replace many of the targeted diagnostics for individual cancers, infectious diseases, metabolic conditions, and other rare or common disorders. The company also
generates actionable individualized information to streamline clinical intervention strategies. MYI Diagnostics was founded by, Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor in 2015. The company is based in San Diego, California.
Women Founded
